Valuation: Lonza Group AG

Capitalization 3.61TCr 4.61TCr 3.99TCr 3.47TCr 6.33TCr 4,23800Cr 6.61TCr 43TCr 17TCr 2,03100Cr 17TCr 17TCr 7,28100Cr P/E ratio 2025
39.8x
P/E ratio 2026 * 31.2x
Enterprise value 3.96TCr 5.06TCr 4.37TCr 3.8TCr 6.93TCr 4,64400Cr 7.24TCr 47TCr 19TCr 2,22500Cr 19TCr 19TCr 7,97900Cr EV / Sales 2025
6.28x
EV / Sales 2026 * 5.43x
Free-Float
93.86%
Yield 2025
0.93%
Yield 2026 * 1.06%
1 day-1.44%
1 week-5.37%
Current month-5.37%
1 month-1.89%
3 months-7.51%
6 months-11.01%
Current year-5.65%
1 week 506.6
Extreme 506.6
535.4
1 month 498
Extreme 498
542.4
Current year 498
Extreme 498
585.6
1 year 467.8
Extreme 467.8
605.2
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 151.7
Extreme 151.7
785.4
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2024
Director of Finance/CFO 54 01/12/2021
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 16/04/2014
Director/Board Member 68 16/04/2014
Director/Board Member 66 26/04/2016
Change 5d. change 1-year change 3-years change Capi.($)
-1.52%-5.37%-11.08%-10.04% 4.61TCr
-2.03%-9.13%+11.72%+21.39% 3.25TCr
+7.14%-12.60%+19.09%+53.36% 3.12TCr
+0.35%+4.61%-3.95%-19.16% 3TCr
-1.53%-2.46%+151.49%+291.51% 1.97TCr
-1.67%+3.65%+52.28%+107.98% 1.46TCr
-0.97%-4.55%+25.79%+4.77% 1.34TCr
+0.76%+4.99%+42.86%+134.94% 1.33TCr
-5.40%-6.75%+122.70%+105.36% 1.24TCr
-4.87%-7.91%+21,691.18%+3,407.17% 1.2TCr
Average -0.59%-2.97%+2,210.21%+409.73% 2.25TCr
Weighted average by Cap. +0.18%-3.63%+1,182.18%+233.62%

Financials

2025 2026 *
Net sales 756.68Cr 966.24Cr 835.61Cr 726.46Cr 1.32TCr 89TCr 1.38TCr 8.95TCr 3.58TCr 43TCr 3.63TCr 3.55TCr 1,52400Cr 725.74Cr 926.74Cr 801.45Cr 696.76Cr 1.27TCr 85TCr 1.33TCr 8.59TCr 3.43TCr 41TCr 3.48TCr 3.4TCr 1,46200Cr
Net income 102.65Cr 131.08Cr 113.36Cr 99Cr 179.75Cr 12TCr 187.67Cr 1.21TCr 485.29Cr 5.77TCr 491.98Cr 481.46Cr 21TCr 116.91Cr 149.29Cr 129.11Cr 112.24Cr 204.71Cr 14TCr 213.74Cr 1.38TCr 552.7Cr 6.57TCr 560.31Cr 548.34Cr 24TCr
Net Debt 346.31Cr 442.23Cr 382.44Cr 332.48Cr 606.41Cr 41TCr 633.13Cr 4.1TCr 1.64TCr 19TCr 1.66TCr 1.62TCr 70TCr 325.11Cr 415.16Cr 359.03Cr 312.13Cr 569.29Cr 38TCr 594.38Cr 3.85TCr 1.54TCr 18TCr 1.56TCr 1.52TCr 66TCr
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
19,771
Date Price Change Volume
06/26/06 507.00 CHF -1.48% 51,567
05/26/05 514.60 CHF -2.09% 1,31,092
04/26/04 525.60 CHF +1.43% 1,04,411
03/26/03 518.20 CHF -2.26% 1,55,266
02/26/02 530.20 CHF -1.12% 1,60,199
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
514.60CHF
Average target price
676.22CHF
Spread / Average Target
+31.41%

Quarterly revenue - Rate of surprise